Friday, September 29, 2023
Friday, September 29, 2023

Contact us 561.316.3330

Michael Derby Is Appointed Technical Director, Regulatory Approvals at Element Materials Technology

Michael Derby has been appointed technical director, regulatory approvals at Element Materials Technology.

Michael Derby served as Director for ACB Europe as well as a senior reviewer for the certification of wireless devices. In this role, he acted as a Telecommunication Certification Body for the Federal Communications Commission (US), a Certification Body for Innovation, Science and Economic Development (Canada), as well as a Notified Body for the European radio equipment directive. In addition to the 13 years spent in product certification and regulatory approval, his career includes 16 years working in commercial test laboratories, with 10 years in the UK and six years in California, US. Michael is one of the world’s leading experts on the integration of wireless modules into host equipment and lead author in both US and European guidance on the subject.

Steve Hayes, Technical Director, Connected Technologies at Element, commented: “We are delighted to add Michael’s industry-leading technical expertise to our rapidly expanding Connected Technologies team. His prolific experience and proven track record as a leading voice in the sector, as well as his profile as a world-renowned expert in the field, will prove invaluable to our ambitious growth strategy.”

Michael Derby added: “I am excited to be taking on the role of supporting Element’s highly knowledgeable team of engaged experts, many of whom not only hold wireless testing and consumer product compliance expertise but also sit on industry working groups and committees. I am looking forward to guiding Element’s team of specialists as they continue to play a first-hand role in the development of the standards we test to.”

Michael started his UK-based role at Element on 1 September and will be responsible for supporting global projects and customers, reporting to Steve Hayes, Element’s Group-wide Connected Technologies Technical Director. He will work closely with teams across Element’s global network of Connected Technology related laboratories and offices.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

MORE EXECUTIVES

CorWave Appoints Magalie Durrèche as Chief Financial Officer

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

Veracyte Names Dr Phillip G Febbo Chief Scientific Officer and Chief Medical Officer

“Phil G Febbo is an exceptional leader with a strong track record of driving successful commercialization of molecular tests through evidence development, guideline inclusion and key opinion leader support,” said Mr. Stapley. “His experience and expertise will be critical to further enhancing our ability to serve our customers and, ultimately, to transforming cancer care for patients all over the world.”

GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

Dr Aaron Tendler is a board-certified psychiatrist based in Palm Beach, Florida, bringing over 20 years of experience as an industry leader researching novel treatments for mental health disorders.

Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

By using this website you agree to accept Medical Device News Magazine Privacy Policy